[Federal Register Volume 63, Number 96 (Tuesday, May 19, 1998)]
[Notices]
[Pages 27590-27591]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-13334]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on February 17, 1998, Roche 
Diagnostic Systems Inc., 1080 U.S. Highway 202, Somerville, New Jersey 
08876-3771, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Lysergic acid diethylamide (7315)..........  I                          
Tetrahydrocannabinols (7370)...............  I                          
Phencyclidine (7471).......................  II                         
Benzoylecgonine (9180).....................  II                         
Methadone (9250)...........................  II                         
Morphine (9300)............................  II                         
------------------------------------------------------------------------


[[Page 27591]]

    The firm plans to manufacture small quantities of the listed 
controlled substances for incorporation in drug of abuse detection 
kits.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than July 20, 1998.

    Dated: May 7, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-13334 Filed 5-18-98; 8:45 am]
BILLING CODE 4410-09-M